HomeELIC • STO
add
Elicera Therapeutics AB
Previous close
kr 4.65
Day range
kr 4.64 - kr 4.97
Year range
kr 0.85 - kr 5.19
Market cap
238.07M SEK
Avg Volume
422.00K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 218.86K | -92.79% |
Operating expense | 8.29M | -2.13% |
Net income | -8.01M | -49.24% |
Net profit margin | -3.66K | -1,969.53% |
Earnings per share | — | — |
EBITDA | -8.07M | -48.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.65M | 12.15% |
Total assets | 46.38M | 12.00% |
Total liabilities | 13.63M | 39.13% |
Total equity | 32.75M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -54.56% | — |
Return on capital | -75.38% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.01M | -49.24% |
Cash from operations | -744.92K | 91.96% |
Cash from investing | 1.00K | — |
Cash from financing | 20.00M | -2.86% |
Net change in cash | 19.25M | 70.05% |
Free cash flow | 2.23M | 130.44% |
About
Founded
2014
Website
Employees
2
